Skip to main content

Advertisement

SpringerLink
Log in

OnabotulinumtoxinA for chronic migraine: a real-life Italian multicenter experience

  • MANAGEMENT AND THERAPY
  • Published:
Neurological Sciences Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Bigal ME, Serrano D, Reed M, Lipton RB (2008) Chronic migraine in the population: burden, diagnosis, and satisfaction with treatment. Neurology 71:559–566

    Article  Google Scholar 

  2. Aurora SK, Dodick DW, Turkel CC, RE DG, Silberstein SD, Lipton RB, Diener HC, Brin MF, PREEMPT 1 Chronic Migraine Study Group (2010) OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial. Cephalalgia 30:793–803

    Article  CAS  Google Scholar 

  3. Diener HC, Dodick DW, Aurora SK, Turkel CC, DeGryse RE, Lipton RB, Silberstein SD, Brin MF, PREEMPT 2 Chronic Migraine Study Group (2010) OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial. Cephalalgia 30:804–814

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. UOS Cefalee e Neurosonologia, Policlinico Universitario Campus Bio-Medico di Roma, Via Alvaro del Portillo, 200, 00128, Rome, Italy

    Fabrizio Vernieri, Matteo Paolucci & Claudia Altamura

  2. Servizio di Statistica Medica, Fondazione Fatebenefratelli per la Ricerca e la Formazione Sanitaria e Sociale, Rome, Italy

    Patrizio Pasqualetti

  3. IRCCS Istituto delle Scienze Neurologiche di Bologna, DIBINEM, Alma Mater Studiorum, Università di Bologna, Bologna, Italy

    Vincenzo Mastrangelo, Giulia Pierangeli & Sabina Cevoli

  4. Istituto Neurologico Carlo Besta, Milan, Italy

    Domenico D’Amico & Licia Grazzi

Authors
  1. Fabrizio Vernieri
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Matteo Paolucci
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Claudia Altamura
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Patrizio Pasqualetti
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Vincenzo Mastrangelo
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Giulia Pierangeli
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Sabina Cevoli
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Domenico D’Amico
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Licia Grazzi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Fabrizio Vernieri.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Vernieri, F., Paolucci, M., Altamura, C. et al. OnabotulinumtoxinA for chronic migraine: a real-life Italian multicenter experience. Neurol Sci 39 (Suppl 1), 171–172 (2018). https://doi.org/10.1007/s10072-018-3393-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10072-018-3393-3

Search

Navigation